A world-renowned Harvard child psychiatrist earned at least $1.6 million in consulting fees from drug makers from 2000 to 2007 but for years did not report much of this income to university officials, according to information given Congressional investigators. By failing to report income, the psychiatrist and a colleague may have violated federal and university research rules designed to police potential conflicts of interest, according to Senator Charles E. Grassley.